Intra-Cellular Therapies, Inc. Annual Return On Equity in % from 2013 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Intra-Cellular Therapies, Inc. quarterly/annual Return On Equity history and growth rate from 2013 to 2023.
  • Intra-Cellular Therapies, Inc. Return On Equity for the quarter ending September 30, 2024 was -9.93 %, a 60.2% increase year-over-year.
  • Intra-Cellular Therapies, Inc. annual Return On Equity for 2023 was -23 %, a 35.8% increase from 2022.
  • Intra-Cellular Therapies, Inc. annual Return On Equity for 2022 was -35.9 %, a 34.6% increase from 2021.
  • Intra-Cellular Therapies, Inc. annual Return On Equity for 2021 was -54.9 %, a 31.6% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -23 +12.9 +35.8% Jan 1, 2023 Dec 31, 2023
2022 -35.9 +19 +34.6% Jan 1, 2022 Dec 31, 2022
2021 -54.9 -13.2 -31.6% Jan 1, 2021 Dec 31, 2021
2020 -41.7 +19.4 +31.7% Jan 1, 2020 Dec 31, 2020
2019 -61.1 -19.3 -46.2% Jan 1, 2019 Dec 31, 2019
2018 -41.8 -15.1 -56.7% Jan 1, 2018 Dec 31, 2018
2017 -26.7 +1.5 +5.33% Jan 1, 2017 Dec 31, 2017
2016 -28.2 +1.69 +5.66% Jan 1, 2016 Dec 31, 2016
2015 -29.9 -6.95 -30.3% Jan 1, 2015 Dec 31, 2015
2014 -22.9 +128 +84.8% Jan 1, 2014 Dec 31, 2014
2013 -151 Jan 1, 2013 Dec 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.